Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Shiver

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Protein Expression and Purification|October 26, 2001
An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramerK M Grimm, W L Trigona, G J Heidecker, et al.
Journal of Virology|December 19, 2000
Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virusT M Fu, D C Freed, W L Trigona, et al.
DNA and Cell Biology|November 1, 1993
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectorsD L Montgomery, J W Shiver, K R Leander, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxinJ J Donnelly, J B Ulmer, L A Hawe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administrationD H Barouch, S Santra, T D Steenbeke, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationN L Letvin, D C Montefiori, Y Yasutomi, et al.
Journal of Virology|July 25, 2000
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infectionM A Egan, W A Charini, M J Kuroda, et al.
Journal of Virology|February 13, 2001
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysD H Barouch, A Craiu, S Santra, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2000
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeysD H Barouch, A Craiu, M J Kuroda, et al.
Science (New York, N.Y.)|October 20, 2000
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccinationD H Barouch, S Santra, J E Schmitz, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Protein Expression and Purification|October 26, 2001
An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramerK M Grimm, W L Trigona, G J Heidecker, et al.
Journal of Virology|December 19, 2000
Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virusT M Fu, D C Freed, W L Trigona, et al.
DNA and Cell Biology|November 1, 1993
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectorsD L Montgomery, J W Shiver, K R Leander, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxinJ J Donnelly, J B Ulmer, L A Hawe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administrationD H Barouch, S Santra, T D Steenbeke, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationN L Letvin, D C Montefiori, Y Yasutomi, et al.
Journal of Virology|July 25, 2000
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infectionM A Egan, W A Charini, M J Kuroda, et al.
Journal of Virology|February 13, 2001
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysD H Barouch, A Craiu, S Santra, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2000
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeysD H Barouch, A Craiu, M J Kuroda, et al.
Science (New York, N.Y.)|October 20, 2000
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccinationD H Barouch, S Santra, J E Schmitz, et al.
Pageof 3